Molecular dynamics of the host response to Streptococcus pneumoniae pneumonia in baboons

Abstract

Background: Bacterial pneumonia remains a leading cause of morbidity and mortality worldwide despite the widespread availability of antibiotics. Novel pneumonia therapies and biomarkers are urgently needed to improve outcomes and advance personalized therapy. Using an established baboon model of S. pneumoniae pneumonia, we sought to characterize the temporal dynamics of pneumonia host responses to identify novel potential diagnostic and therapeutic molecular targets.

Methods: We performed whole blood transcriptomics, unbiased proteomics, and peripheral cytokine measurements serially in baboons inoculated with S. pneumoniae (n = 23) or saline (n = 10) and modeled the peripheral blood host response using principal components analysis and complex sparse logistic regression. Differentially expressed genes were analyzed for pathway analysis.

Results: Inoculated animals developed characteristic signs and symptoms of pneumonia. A 39-gene signature was derived that classified S. pneumoniae infection with high accuracy (auROC 0.9 and 0.99 at 24 and 48 h post-inoculation, respectively). Similar performance was observed for 48-h biomarker signatures derived from peripheral blood plasma proteomic and cytokine measurements (both auROC >0.9). The gene signature retained strong diagnostic performance (auROC = 0.88) when transformed to human orthologs and applied to patients with acute respiratory illness (n = 34) or healthy controls (n = 20). Pathway analysis at 48 h identified down-regulation of mitophagy and glucocorticoid signaling in peripheral blood.

Conclusions: We report novel peripheral blood gene and protein expression signatures of S. pneumoniae pneumonia that could improve pneumonia diagnosis and found distinct pathways that may be amenable to modulation. Our findings illustrate how non-human primate models of bacterial pneumonia can successfully translate biomarker discoveries to patients.

Keywords

animal models / bacterial pneumonia / gene expression profiling / Streptococcus pneumoniae / rapid diagnostic tests

References

[1] Diseases, G.B.D, Injuries, C. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396:1204-1222.

[2] O'Brien KL, Wolfson LJ, Watt JP, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet. 2009;374:893-902.

[3] Falade AG, Lagunju IA, Bakare RA, Odekanmi AA, Adegbola RA. Invasive pneumococcal disease in children aged <5 years admitted to 3 urban hospitals in Ibadan. Nigeria Clin Infect Dis. 2009;48(Suppl 2):S190-S196.

[4] Smith MD, Derrington P, Evans R, et al. Rapid diagnosis of bacteremic pneumococcal infections in adults by using the Binax NOW Streptococcus pneumoniae urinary antigen test: a prospective, controlled clinical evaluation. J Clin Microbiol. 2003;41:2810-2813.

[5] Gilbert DN, Leggett JE, Wang L, et al. Enhanced detection of community-acquired pneumonia pathogens with the BioFire(R) pneumonia FilmArray(R) panel. Diagn Microbiol Infect Dis. 2021;99:115246.

[6] Abril MK, Barnett AS, Wegermann K, et al. Diagnosis of Capnocytophaga canimorsus sepsis by whole-genome next-generation sequencing. Open Forum Infect Dis. 2016;3:ofw144.

[7] Kamat IS, Ramachandran V, Eswaran H, Guffey D, Musher DM. Procalcitonin to distinguish viral from bacterial pneumonia: a systematic review and meta-analysis. Clin Infect Dis. 2020;70:538-542.

[8] Halabi S, Shiber S, Paz M, et al. Host test based on tumor necrosis factor-related apoptosis-inducing ligand, interferon gamma-induced protein-10 and C-reactive protein for differentiating bacterial and viral respiratory tract infections in adults: diagnostic accuracy study. Clin Microbiol Infect. 2023;29:1159-1165.

[9] Shapiro NI, Filbin MR, Hou PC, et al. Diagnostic accuracy of a bacterial and viral biomarker point-of-care test in the outpatient setting. JAMA Netw Open. 2022;5:e2234588.

[10] Wee LE, Lye DC, Lee V. Developments in pneumonia and priorities for research. Lancet Respir Med. 2023;11:1046-1047.

[11] Zaas AK, Burke T, Chen M, et al. A host-based RT-PCR gene expression signature to identify acute respiratory viral infection. Sci Transl Med. 2013;5:203ra126.

[12] Tsalik EL, Henao R, Nichols M, et al. Host gene expression classifiers diagnose acute respiratory illness etiology. Sci Transl Med. 2016;8:322ra311.

[13] Almansa R, Herrero-Rodriguez C, Martinez-Huelamo M, et al. A host transcriptomic signature for identification of respiratory viral infections in the community. Eur J Clin Investig. 2021;51:e13626.

[14] Bauer W, Kappert K, Galtung N, et al. A novel 29-messenger RNA host-response assay from whole blood accurately identifies bacterial and viral infections in patients presenting to the emergency department with suspected infections: a prospective observational study. Crit Care Med. 2021;49:1664-1673.

[15] Mayhew MB, Buturovic L, Luethy R, et al. A generalizable 29-mRNA neural-network classifier for acute bacterial and viral infections. Nat Commun. 2020;11:1177.

[16] Ramilo O, Allman W, Chung W, et al. Gene expression patterns in blood leukocytes discriminate patients with acute infections. Blood. 2007;109:2066-2077.

[17] Sweeney TE, Wong HR, Khatri P. Robust classification of bacterial and viral infections via integrated host gene expression diagnostics. Sci Transl Med. 2016;8:346ra391.

[18] Tillekeratne LG, Suchindran S, Ko ER, et al. Previously derived host gene expression classifiers identify bacterial and viral etiologies of acute febrile respiratory illness in a south Asian population. Open Forum Infect Dis. 2020;7:ofaa194.

[19] Dressman HK, Hans C, Bild A, et al. Gene expression profiles of multiple breast cancer phenotypes and response to neoadjuvant chemotherapy. Clin Cancer Res. 2006;12:819-826.

[20] Langley RJ, Tsalik EL, van Velkinburgh JC, et al. An integrated clinico-metabolomic model improves prediction of death in sepsis. Sci Transl Med. 2013;5:195ra195.

[21] Langley RJ, Tipper JL, Bruse S, et al. Integrative “omic” analysis of experimental bacteremia identifies a metabolic signature that distinguishes human sepsis from systemic inflammatory response syndromes. Am J Respir Crit Care Med. 2014;190:445-455.

[22] Tsalik EL, Willig LK, Rice BJ, et al. Renal systems biology of patients with systemic inflammatory response syndrome. Kidney Int. 2015;88:804-814.

[23] Welty-Wolf KE, Carraway MS, Miller DL, et al. Coagulation blockade prevents sepsis-induced respiratory and renal failure in baboons. Am J Respir Crit Care Med. 2001;164:1988-1996.

[24] Kraft BD, Piantadosi CA, Benjamin AM, et al. Development of a novel preclinical model of pneumococcal pneumonia in nonhuman primates. Am J Respir Cell Mol Biol. 2014;50:995-1004.

[25] Fredenburgh LE, Kraft BD, Hess DR, et al. Effects of inhaled CO administration on acute lung injury in baboons with pneumococcal pneumonia. Am J Physiol Lung Cell Mol Physiol. 2015;309:L834-L846.

[26] Dalli J, Kraft BD, Colas RA, et al. The regulation of Proresolving lipid mediator profiles in baboon pneumonia by inhaled carbon monoxide. Am J Respir Cell Mol Biol. 2015;53:314-325.

[27] Chen L, Welty-Wolf KE, Kraft BD. Nonhuman primate species as models of human bacterial sepsis. Lab Anim (NY). 2019;48:57-65.

[28] Chen L, Kraft BD, Roggli VL, et al. Heparin-based blood purification attenuates organ injury in baboons with Streptococcus pneumoniae pneumonia. Am J Physiol Lung Cell Mol Physiol. 2021;321:L321-L335.

[29] Fracica PJ, Knapp MJ, Piantadosi CA, et al. Responses of baboons to prolonged hyperoxia: physiology and qualitative pathology. J Appl Physiol (1985). 1991;71:2352-2362.

[30] Harrison HR, Alexander ER, Chiang WT, et al. Experimental nasopharyngitis and pneumonia caused by chlamydia trachomatis in infant baboons: histopathologic comparison with a case in a human infant. J Infect Dis. 1979;139:141-146.

[31] Zou H, Hastie T. Regularization and variable selection via the elastic net. J R Stat Soc Series B Stat Methodology. 2005;67(2):301-320.

[32] Ma C, Storer CE, Chandran U, et al. Crohn's disease-associated ATG16L1 T300A genotype is associated with improved survival in gastric cancer. EBioMedicine. 2021;67:103347.

[33] Eastel JM, Lam KW, Lee NL, et al. Application of NanoString technologies in companion diagnostic development. Expert Rev Mol Diagn. 2019;19:591-598.

[34] Tsalik EL, Henao R, Montgomery JL, et al. Discriminating bacterial and viral infection using a rapid host gene expression test. Crit Care Med. 2021;49:1651-1663.

[35] Ko ER, Henao R, Frankey K, et al. Prospective validation of a rapid host gene expression test to discriminate bacterial from viral respiratory infection. JAMA Netw Open. 2022;5:e227299.

[36] Tsalik EL, Khine A, Talebpour A, et al. Rapid, sample-to-answer host gene expression test to diagnose viral infection. Open Forum Infect Dis. 2019;6:ofz466.

[37] Cook DB, McLucas BC, Montoya LA, et al. Multiplexing protein and gene level measurements on a single Luminex platform. Methods. 2019;158:27-32.

[38] Ramilo O, Mejias A. Shifting the paradigm: host gene signatures for diagnosis of infectious diseases. Cell Host Microbe. 2009;6:199-200.

[39] McClain MT, Constantine FJ, Henao R, et al. Dysregulated transcriptional responses to SARS-CoV-2 in the periphery. Nat Commun. 2021;12:1079.

[40] Ricketson LJ, Vanderkooi OG, Wood ML, Leal J, Kellner JD. Clinical features and outcomes of serotype 19A invasive pneumococcal disease in Calgary, Alberta. Can J Infect Dis Med Microbiol. 2014;25:e71-e75.

[41] Pelton SI, Huot H, Finkelstein JA, et al. Emergence of 19A as virulent and multidrug resistant pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2007;26:468-472.

[42] Seyoum B, Yano M, Pirofski LA. The innate immune response to Streptococcus pneumoniae in the lung depends on serotype and host response. Vaccine. 2011;29:8002-8011.

[43] Lill M, Koks S, Soomets U, et al. Peripheral blood RNA gene expression profiling in patients with bacterial meningitis. Front Neurosci. 2013;7:33.

[44] Casadevall A, Pirofski L. Host-pathogen interactions: the attributes of virulence. J Infect Dis. 2001;184:337-344.

[45] Tu C, Rudnick PA, Martinez MY, et al. Depletion of abundant plasma proteins and limitations of plasma proteomics. J Proteome Res. 2010;9:4982-4991.

[46] Athale J, Ulrich A, MacGarvey NC, et al. Nrf2 promotes alveolar mitochondrial biogenesis and resolution of lung injury in Staphylococcus aureus pneumonia in mice. Free Radic Biol Med. 2012;53:1584-1594.

[47] Suliman HB, Kraft B, Bartz R, Chen L, Welty-Wolf KE, Piantadosi CA. Mitochondrial quality control in alveolar epithelial cells damaged by S. aureus pneumonia in mice. Am J Physiol Lung Cell Mol Physiol. 2017;313:L699-L709.

[48] Kraft BD, Pavlisko EN, Roggli VL, Piantadosi CA, Suliman HB. Alveolar mitochondrial quality control during acute respiratory distress syndrome. Lab Investig. 2023;103:100197.

[49] Chang AL, Ulrich A, Suliman HB, Piantadosi CA. Redox regulation of mitophagy in the lung during murine Staphylococcus aureus sepsis. Free Radic Biol Med. 2015;78:179-189.

[50] Wu Z, Wang Y, Lim J, et al. Ubiquitination of ABCE1 by NOT4 in response to mitochondrial damage links Co-translational quality control to PINK1-directed Mitophagy. Cell Metab. 2018;28:130-144. e137.

[51] Lin J, Chen K, Chen W, et al. Paradoxical Mitophagy regulation by PINK1 and TUFm. Mol Cell. 2020;80:607-620.e612.

[52] Xu G, Li T, Chen J, et al. Autosomal dominant retinitis pigmentosa-associated gene PRPF8 is essential for hypoxia-induced mitophagy through regulating ULK1 mRNA splicing. Autophagy. 2018;14:1818-1830.

[53] Kraft BD, Chen L, Suliman HB, Piantadosi CA, Welty-Wolf KE. Peripheral blood mononuclear cells demonstrate mitochondrial damage clearance during sepsis. Crit Care Med. 2019;47:651-658.

[54] Sloan KE, Bohnsack MT, Watkins NJ. The 5S RNP couples p53 homeostasis to ribosome biogenesis and nucleolar stress. Cell Rep. 2013;5:237-247.

[55] Torres A, Sibila O, Ferrer M, et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial. JAMA. 2015;313:677-686.

[56] Fernandez-Serrano S, Dorca J, Garcia-Vidal C, et al. Effect of corticosteroids on the clinical course of community-acquired pneumonia: a randomized controlled trial. Crit Care. 2011;15:R96.

[57] Dequin PF, Meziani F, Quenot JP, et al. Hydrocortisone in severe community-acquired pneumonia. N Engl J Med. 2023;388:1931-1941.

[58] Burnley B, Jones HP. Corticotropin-releasing hormone improves survival in pneumococcal pneumonia by reducing pulmonary inflammation. Physiol Rep. 2017;5:e13000.

[59] Dela Cruz CS, Evans SE, Restrepo MI, et al. Understanding the host in the management of pneumonia. An official American Thoracic Society workshop report. Ann Am Thorac Soc. 2021;18:1087-1097.

[60] Bagga B, Woods CW, Veldman TH, et al. Comparing influenza and RSV viral and disease dynamics in experimentally infected adults predicts clinical effectiveness of RSV antivirals. Antivir Ther. 2013;18:785-791.

[61] McClain MT, Park LP, Nicholson B, et al. Longitudinal analysis of leukocyte differentials in peripheral blood of patients with acute respiratory viral infections. J Clin Virol. 2013;58:689-695.

[62] Rose JJ, Voora D, Cyr DD, et al. Gene expression profiles link respiratory viral infection, platelet response to aspirin, and acute myocardial infarction. PLoS One. 2015;10:e0132259.

[63] Burke TW, Henao R, Soderblom E, et al. Nasopharyngeal protein biomarkers of acute respiratory virus infection. EBioMedicine. 2017;17:172-181.

[64] Chen B, Chen M, Paisley J, et al. Bayesian inference of the number of factors in gene-expression analysis: application to human virus challenge studies. BMC Bioinformatics. 2010;11:552.

[65] Zaas AK, Chen M, Varkey J, et al. Gene expression signatures diagnose influenza and other symptomatic respiratory viral infections in humans. Cell Host Microbe. 2009;6(3):207-217.

RIGHTS & PERMISSIONS

2025 The Author(s). Animal Models and Experimental Medicine published by John Wiley & Sons Australia, Ltd on behalf of The Chinese Association for Laboratory Animal Sciences.